ClinConnect ClinConnect Logo
Search / Trial NCT04280809

Effects of Low-level Laser Therapy After Surgical Removal of Impacted Lower Third Molar

Launched by UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY · Feb 20, 2020

Trial Information

Current as of July 23, 2025

Completed

Keywords

ClinConnect Summary

Goal: The aim of this study was to evaluate the effects of low-level laser (LLL) after surgical removal of impacted lower third molars (ILTM), including pain level, postoperative facial swelling, trismus and non-stimulated saliva secretory immunoglobulin A (sIgA).

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • had two impacted lower third molars symmetrically in the same position as the classifications of Pell- Gregory and Winter diagnosed by 2D panoramic radiography
  • Exclusion Criteria:
  • Patients with systemic diseases such as cardiovascular disease, hypertension, diabetes mellitus, pregnant, local infections
  • refused to participate in the study
  • patients who did not follow-up visit would be excluded

About University Of Medicine And Pharmacy At Ho Chi Minh City

The University of Medicine and Pharmacy at Ho Chi Minh City is a premier academic institution dedicated to advancing healthcare education and research in Vietnam. Renowned for its commitment to excellence in medical training, the university actively engages in innovative clinical trials aimed at improving patient outcomes and addressing pressing health challenges. By leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the institution fosters collaboration between researchers, clinicians, and industry partners, ensuring the translation of scientific discoveries into effective medical practices. Through its rigorous ethical standards and dedication to patient safety, the university plays a vital role in enhancing the quality of healthcare in the region.

Locations

Ho Chi Minh City, Dictrict 5, Vietnam

Ho Chi Minh City, , Vietnam

Patients applied

0 patients applied

Trial Officials

Ly TB Nguyen, PhD

Study Director

University of Medicine and Pharmacy at Ho Chi Minh City

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials